loadpatents
name:-0.021064043045044
name:-0.0085229873657227
name:-0.00045609474182129
Coe; Jotham W. Patent Filings

Coe; Jotham W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Coe; Jotham W..The latest application filed is for "pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss".

Company Profile
0.8.16
  • Coe; Jotham W. - Niantic CT
  • Coe; Jotham W. - Mystic CT
  • Coe; Jotham W. - Belmont MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2-azabicyclo[3.3.1]nonane derivatives
Grant RE40,838 - Coe , et al. July 7, 2
2009-07-07
Heteroaryl fused azapolycyclic compounds
Grant 7,456,177 - Allen , et al. November 25, 2
2008-11-25
Diazabicyclic compounds useful in the treatment of CNS and other disorders
Grant 7,442,694 - Coe , et al. October 28, 2
2008-10-28
3-azabicyclo[3.2.1]octane derivatives
Grant 7,241,887 - Coe , et al. July 10, 2
2007-07-10
2-Azabicyclo[3.3.1]nonane derivatives
Grant 7,056,930 - Coe , et al. June 6, 2
2006-06-06
Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
App 20050043406 - Coe, Jotham W. ;   et al.
2005-02-24
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
App 20050043407 - Coe, Jotham W. ;   et al.
2005-02-24
4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
App 20050032837 - McHardy, Stanton ;   et al.
2005-02-10
Aryl fused azapolycyclic compounds
App 20050020616 - Coe, Jotham W. ;   et al.
2005-01-27
Heteroaryl fused azapolycyclic compounds
App 20050020830 - Allen, Martin P. ;   et al.
2005-01-27
3-Azabicyclo[3.2.1]octane derivatives
App 20040259859 - Coe, Jotham W. ;   et al.
2004-12-23
Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
App 20040224962 - Coe, Jotham W. ;   et al.
2004-11-11
Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
App 20040224963 - Coe, Jotham W. ;   et al.
2004-11-11
2-Azabicyclo[3.3.1]nonane derivatives
App 20040204445 - Coe, Jotham W. ;   et al.
2004-10-14
4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
App 20040204453 - McHardy, Stanton ;   et al.
2004-10-14
Pharmaceutical composition and method of modulating cholinergic function in a mammal
App 20040167200 - Coe, Jotham W. ;   et al.
2004-08-26
Diazabicyclic compounds useful in the treatment of CNS and other disorders
App 20040106603 - Coe, Jotham W. ;   et al.
2004-06-03
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
App 20030133951 - Coe, Jotham W. ;   et al.
2003-07-17
Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
App 20030109544 - Harrigan, Edmund P. ;   et al.
2003-06-12
Pharmaceutical composition and method of modulating cholinergic function in a mammal
App 20030008892 - Coe, Jotham W. ;   et al.
2003-01-09
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
App 20010036943 - Coe, Jotham W. ;   et al.
2001-11-01
Pyrimidine derivatives for enhancing antitumor activity
Grant 5,491,234 - Coe , et al. February 13, 1
1996-02-13
Quinazolines derivatives for enhancing antitumor activity
Grant 5,444,062 - Coe , et al. August 22, 1
1995-08-22
Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
Grant 4,535,157 - Meltzer , et al. August 13, 1
1985-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed